Our present data implied the importance of HOMA-IR measurement in elderly cancer patients, because those with high HOMA-IR scores may be at a high risk for developing cognitive impairment and may benefit from early treatment, such as the use of biguanide, to reduce insulin sensitivity. This evidence concerns the gene INS and Cognitive impairment.